172 related articles for article (PubMed ID: 20549321)
1. Thymosin alpha 1 is associated with improved cellular immunity and reduced infection rate in severe acute pancreatitis patients in a double-blind randomized control study.
Wang X; Li W; Niu C; Pan L; Li N; Li J
Inflammation; 2011 Jun; 34(3):198-202. PubMed ID: 20549321
[TBL] [Abstract][Full Text] [Related]
2. [Immune and inflammation confusion in severe sepsis and effects of bi-immunomodulation therapy: a prospective, randomized, controlled clinical trial].
Zhou LX; Tan JJ; Li YN; Luo HT; Shao YH; Qiang XH; Yu TO; Ma MY; Mao KJ; Fang B
Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(15):1028-33. PubMed ID: 19595251
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial.
Wu J; Zhou L; Liu J; Ma G; Kou Q; He Z; Chen J; Ou-Yang B; Chen M; Li Y; Wu X; Gu B; Chen L; Zou Z; Qiang X; Chen Y; Lin A; Zhang G; Guan X
Crit Care; 2013 Jan; 17(1):R8. PubMed ID: 23327199
[TBL] [Abstract][Full Text] [Related]
4. [Effect of continuous blood purification and thymosin alpha1 on the cellular immunity in patients with severe sepsis: a prospective, randomized, controlled clinical trial].
Li YN; Zhou LX; Qiang XH; Yu TO; Mao KJ; Feng B; Wen WB; Zou YC; Li WY; Li C
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Mar; 21(3):139-42. PubMed ID: 19278581
[TBL] [Abstract][Full Text] [Related]
5. Thymosin alpha 1 improves severe acute pancreatitis in rats via regulation of peripheral T cell number and cytokine serum level.
Yao W; Zhu Q; Yuan Y; Qiao M; Zhang Y; Zhai Z
J Gastroenterol Hepatol; 2007 Nov; 22(11):1866-71. PubMed ID: 17914961
[TBL] [Abstract][Full Text] [Related]
6. [Clinical effects of ulinastatin and thymosin alpha1 on immune-modulation in septic patients].
Su L; Meng FS; Tang YQ; Wen Q; Liu YS; Tang LQ; Duan PK; Luo RJ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Mar; 21(3):147-50. PubMed ID: 19278583
[TBL] [Abstract][Full Text] [Related]
7. Treatment of patients with severe sepsis using ulinastatin and thymosin alpha1: a prospective, randomized, controlled pilot study.
Chen H; He MY; Li YM
Chin Med J (Engl); 2009 Apr; 122(8):883-8. PubMed ID: 19493408
[TBL] [Abstract][Full Text] [Related]
8. The Therapeutic Effects of Thymosin α1 Combined with Human Immunoglobulin (Ig) and Bundles on Severe Sepsis: a Retrospective Study.
Li Y; Li CS
Clin Lab; 2015; 61(8):907-16. PubMed ID: 26427133
[TBL] [Abstract][Full Text] [Related]
9. Thymosin α1 plus routine treatment inhibit inflammatory reaction and improve the quality of life in AECOPD patients.
Jia Z; Feng Z; Tian R; Wang Q; Wang L
Immunopharmacol Immunotoxicol; 2015; 37(4):388-92. PubMed ID: 26250523
[TBL] [Abstract][Full Text] [Related]
10. A new immunomodulatory therapy for severe sepsis: Ulinastatin Plus Thymosin {alpha} 1.
Li Yumin ; Chen Hao ; Li Xun ; Zhou Wence ; He Minyan ; Chiriva-Internati M; Wachtel MS; Frezza EE
J Intensive Care Med; 2009; 24(1):47-53. PubMed ID: 19033321
[TBL] [Abstract][Full Text] [Related]
11. Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study.
Mutchnick MG; Lindsay KL; Schiff ER; Cummings GD; Appelman HD; Peleman RR; Silva M; Roach KC; Simmons F; Milstein S; Gordon SC; Ehrinpreis MN
J Viral Hepat; 1999 Sep; 6(5):397-403. PubMed ID: 10607256
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of thymosin α 1 in nonclinical models of the immune-suppressing indications melanoma and sepsis.
King RS; Tuthill C
Expert Opin Biol Ther; 2015; 15 Suppl 1():S41-9. PubMed ID: 25643200
[TBL] [Abstract][Full Text] [Related]
13. Thymosin alpha 1 in the prevention of infected pancreatic necrosis following acute necrotising pancreatitis (TRACE trial): protocol of a multicentre, randomised, double-blind, placebo-controlled, parallel-group trial.
Zhou J; Mao W; Ke L; Chen T; He W; Pan X; Chen M; He C; Gu W; Wu J; Song J; Ni H; Tu J; Sun J; Zhang G; Chen W; Xue B; Zhao X; Shao M; Liu Y; Tong Z; Li W;
BMJ Open; 2020 Sep; 10(9):e037231. PubMed ID: 32994239
[TBL] [Abstract][Full Text] [Related]
14. The effect of thymosin α1 for prevention of infection in patients with severe acute pancreatitis.
Yang N; Ke L; Tong Z; Li W
Expert Opin Biol Ther; 2018 Jul; 18(sup1):53-60. PubMed ID: 30063854
[TBL] [Abstract][Full Text] [Related]
15. Human leukocyte antigen-DR expression on peripheral monocytes may be an early marker for secondary infection in severe acute pancreatitis.
Lin ZQ; Guo J; Xia Q; Yang XN; Huang W; Huang ZW; Xue P
Hepatogastroenterology; 2013; 60(128):1896-902. PubMed ID: 24719924
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of thymosin alpha1 therapy for chronic hepatitis B patients.
Arase Y; Tsubota A; Suzuki Y; Suzuki F; Kobayashi M; Someya T; Akuta N; Hosaka T; Saitoh S; Ikeda K; Kobayashi M; Kumada H
Intern Med; 2003 Oct; 42(10):941-6. PubMed ID: 14606705
[TBL] [Abstract][Full Text] [Related]
17. The role of Fas expression on the occurrence of immunosuppression in severe acute pancreatitis.
Qin Y; Pinhu L; You Y; Sooranna S; Huang Z; Zhou X; Yin Y; Song S
Dig Dis Sci; 2013 Nov; 58(11):3300-7. PubMed ID: 23861115
[TBL] [Abstract][Full Text] [Related]
18. Clinical observation of immunity for severe acute pancreatitis.
Liu Z; Shen Y; Cui N; Yang J
Inflammation; 2011 Oct; 34(5):426-31. PubMed ID: 20842417
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of thymosin α1 and interferon α for the treatment of severe acute pancreatitis in a rat model.
Wang X; Zeng X; Yang B; Zhao S; Chen W; Guo X
Mol Med Rep; 2015 Nov; 12(5):6775-81. PubMed ID: 26330363
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials.
Liu F; Wang HM; Wang T; Zhang YM; Zhu X
BMC Infect Dis; 2016 Sep; 16():488. PubMed ID: 27633969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
